HKUST Library Institutional Repository Banner

HKUST Institutional Repository >
Biology >
BIOL Master Theses >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1783.1/3805
Title: Study of calreticulin mediated NY-ESO-1 immunogenicity in human dendritic cells
Authors: Zeng, Chenjie
Issue Date: 2008
Abstract: NY-ESO-1 is one of the most immunogenic cancer/testis antigens (CTAs) ever discovered. The immunogenicity of NY-ESO-1 mainly relies on its cross presentation in dendritic cells (DCs) to generate specific cytotoxic T lymphocyte (CTL) responses against NY-ESO-1-expressing cancer cells. Calreticulin (CRT) has been identified as a receptor for NY-ESO-1 on DC surface. CRT has been shown to efficiently bind antigens to DCs and to elicit an antigen-specific CTL response. Several receptors for CRT itself on DC surface have been reported. In this thesis, two approaches have been studied to enhance the immunogenicity of NY-ESO-1. In the first approach, the level of CRT expression on DC surface was up-regulated by calyculin A and the binding of NY-ESO-1 to DCs was increased. The function of the CTLs generated from DCs pulsed with calyculin A and NY-ESO-1 protein or NY-ESO-1 protein alone was evaluated by cytotoxicity assay and CD8+ T cell activation assay. The results showed that calyculin A was able to significantly augment the specific CTL responses against NY-ESO-1-expressing cancer cells. In the second approach, the binding of NY-ESO-1 in NY-ESO-1/CRT fusion protein to DCs was found to be more efficient than NY-ESO-1 protein alone. The function of the CTLs induced by NY-ESO-1/CRT fusion protein or NY-ESO-1 protein was evaluated by cytotoxicity assay and CD8+ T cell activation assay. The results showed that NY-ESO-1/CRT fusion protein was more effective in stimulating the NY-ESO-1-specific CTL responses than NY-ESO-1 protein alone. These data demonstrate that both calyculin A and NY-ESO-1/CRT fusion protein are able to enhance the immunogenicity of NY-ESO-1. This study may provide information for developing new strategies for vaccines against NY-ESO-1-expressing cancers.
Description: Thesis (M.Phil.)--Hong Kong University of Science and Technology, 2008
xvi, 131 leaves : ill. ; 30 cm
HKUST Call Number: Thesis BIOL 2008 Zeng
URI: http://hdl.handle.net/1783.1/3805
Appears in Collections:BIOL Master Theses

Files in This Item:

File Description SizeFormat
th_redirect.html0KbHTMLView/Open

All items in this Repository are protected by copyright, with all rights reserved.